Aspirin dilemma: to stop or not to stop during brain bleed treatment?
NCT ID NCT07240454
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether people with a chronic subdural hematoma (a slow brain bleed) who are already taking aspirin should continue or stop it while receiving non-surgical care. Researchers will follow 143 participants for 6 months to see if the hematoma comes back or worsens. The goal is to provide better guidance on managing aspirin use in this situation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Aspirin
What this could lead to
If it works, this could help doctors give clearer guidance on whether to keep taking aspirin during conservative treatment for chronic subdural hematoma, potentially reducing the risk of the hematoma coming back or getting worse.
What could go wrong
This is a relatively small trial (143 people) and is not a late-stage study, so results may not apply to everyone. The main risk is that continuing aspirin might increase bleeding, while stopping it could raise the chance of a heart attack or stroke.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SUBDURAL HEMATOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianjin Medical University General Hospital
RECRUITINGTianjin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xuanwu Hospital Capital Medical University
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••